Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Hsu

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Cancer Research|July 26, 2014
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayChen-Yuan Lin, Hung-Jen Chen, Cheng-Chung Huang, et al.
Nature Cell Biology|February 22, 2011
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAsChun-Ju Chang, Chi-Hong Chao, Weiya Xia, et al.
Cancer Research|April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell FunctionXixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
American Journal of Cancer Research|March 21, 2020
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinomaXian Sun, Chia-Wei Li, Wei-Jan Wang, et al.
Theranostics|April 16, 2020
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathwayChenhao Zhou, Chunxiao Liu, Wenjie Liu, et al.
Molecular Cancer Therapeutics|May 26, 2011
Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferaseChun-Te Chen, Hirohito Yamaguchi, Hong-Jen Lee, et al.
ACS Sensors|February 20, 2020
Digital Receptor Occupancy Assay in Quantifying On- and Off-Target Binding Affinities of Therapeutic AntibodiesChao-Kai Chou, Yen-Liang Liu, Yuan-I Chen, et al.
American Journal of Cancer Research|April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cellsYe Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
American Journal of Translational Research|January 29, 2015
Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cellsLongfei Huo, Chia-Wei Li, Tzu-Hsuan Huang, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Cancer Research|July 26, 2014
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayChen-Yuan Lin, Hung-Jen Chen, Cheng-Chung Huang, et al.
Nature Cell Biology|February 22, 2011
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAsChun-Ju Chang, Chi-Hong Chao, Weiya Xia, et al.
Cancer Research|April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell FunctionXixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
American Journal of Cancer Research|March 21, 2020
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinomaXian Sun, Chia-Wei Li, Wei-Jan Wang, et al.
Theranostics|April 16, 2020
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathwayChenhao Zhou, Chunxiao Liu, Wenjie Liu, et al.
Molecular Cancer Therapeutics|May 26, 2011
Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferaseChun-Te Chen, Hirohito Yamaguchi, Hong-Jen Lee, et al.
ACS Sensors|February 20, 2020
Digital Receptor Occupancy Assay in Quantifying On- and Off-Target Binding Affinities of Therapeutic AntibodiesChao-Kai Chou, Yen-Liang Liu, Yuan-I Chen, et al.
American Journal of Cancer Research|April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cellsYe Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
American Journal of Translational Research|January 29, 2015
Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cellsLongfei Huo, Chia-Wei Li, Tzu-Hsuan Huang, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Pageof 11